Considerable attention has recently been given to the expansion by the European Commission of its theories of harm in merger control, in particular regarding innovation.1 But the Commission’s latest addition to its theory of harm toolkit for horizontal mergers is in fact a static one. Indeed, in its in-depth review of the Novelis/Aleris merger, 2 the Commission considered a novel pivotality theory of harm as a central part of its case.3